OncoLink Cancer Treatment and Resources
OncoLink Cancer Treatment and Resources
OncoLink Cancer News - HealthDay

Screening May Reduce Risk for Late-Stage CRC by 70 Percent

Monday, March 4, 2013 (Last Updated: 03/05/2013)

MONDAY, March 4 (HealthDay News) -- For average-risk adults, screening colonoscopy is associated with a significant decrease in the risk of any colorectal cancer (CRC) and of right colon cancer; and interventions using electronic health records (EHRs) increase screening rates, according to two studies published in the March 5 issue of the Annals of Internal Medicine.

Chyke A. Doubeni, M.D., M.P.H., of the University of Pennsylvania in Philadelphia, and colleagues examined the effectiveness of screening colonoscopy using data from 1,039 average-risk adults enrolled in four U.S. health plans. In analyses restricted to 471 eligible case patients and 509 matched controls, the researchers found that 2.8 percent of case patients and 9.0 percent of controls had undergone screening colonoscopy (adjusted odds ratios, 0.29 for any late-stage CRC; 0.36 for right colon cancer; and 0.26 for left colon/rectum cancer). The odds of overall CRC and left colon cancer, but not right colon cancer, were significantly reduced with sigmoidoscopy.

Beverly B. Green, M.D., M.P.H., of the University of Washington School of Medicine in Seattle, and colleagues assessed whether interventions using EHRs, automated mailings, and stepped increases in support improved adherence to CRC screening over two years among 4,675 adults aged 50 to 73 years not current for CRC screening. The interventions included usual care; EHR-linked mailings; EHR-linked mailings with telephone assistance; or EHR-linked mailings, telephone assistance, and nurse navigation. The researchers found that participants in intervention groups were significantly more likely to be current for CRC screening for both years, compared with usual care.

"Compared with usual care, a centralized, EHR-linked, mailed CRC screening program led to twice as many persons being current for screening over two years," Green and colleagues write. "Assisted and navigated interventions led to smaller but significant stepped increases compared with the automated intervention only. The rapid growth of EHRs provides opportunities for spreading this model broadly."

Full Text - Doubeni (subscription or payment may be required)
Full Text - Green (subscription or payment may be required)

Specialties Urology
Family Practice
Geriatrics
Internal Medicine
Nursing
Radiology
Surgery

Health News Copyright © 2013 HealthDay. All rights reserved.

Cancer Types
Bone Cancer
Brain Tumors
Breast Cancer
Carcinoid Tumors
Endocrine System Cancers
Gastrointestinal Cancers
Gynecologic Cancers
Head and Neck Cancers
Leukemia
Lung Cancers
Lymphomas
Myelomas
Pediatric Cancers
Penile Cancer
Prostate Cancer
Sarcomas
Skin Cancers
Testicular Cancer
Thyroid Cancer
Urinary Tract Cancers
OncoLink Vet

Cancer Treatment
Biologic Therapy
Bone Marrow Transplants
Chemotherapy

Clinical Trials
Complementary Medicine
Gene Therapy
General Treatment Concerns
Hormone Therapy
PDT Center
Proton Therapy
Radiation Oncology
Surgical Oncology
Targeted Therapies
Vaccine Therapies

Cancer Support
Caregivers
Hospice Care and Bereavement
Nutrition and Cancer
Sexuality & Fertility
Side Effects
Support
Survivorship
Exercise and Cancer

Cancer Resources
Cancer News
OncoLink University
Nurses' Notes
Conferences
Newly Diagnosed Patients
Causes and Prevention
Legal and Financial Information for Patients
LGBT Resources
NCI Resources
Global Resources
Cancer Resource List
Resources for Young Adults

OncoLink Media Library
OncoLink TV
Book, Music and Video Reviews


Ask the Experts
Brown Bag Chat
Tracy's Corner

About OncoLink
About OncoLink
Giving to OncoLink
Contact Information
Usage Policy
Editorial Board
How to Partner with OncoLink
Link to OncoLink
Mission Statement

OncoLink Cancer Resources RSS What's New RSS